Biological role of prolyl 3-hydroxylation in type IV collagen

Elena Pokidysheva, Sergei Boudko, Janice Vranka, Keith Zientek, Kerry Maddox, Markus Moser, Reinhard Fässler, Jerry Ware, Hans Peter Bächinger

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Collagens constitute nearly 30% of all proteins in our body. Type IV collagen is a major and crucial component of basement membranes. Collagen chains undergo several posttranslational modifications that are indispensable for proper collagen function. One of these modifications, prolyl 3-hydroxylation, is accomplished by a family of prolyl 3-hydroxylases (P3H1, P3H2, and P3H3). The present study shows that P3H2-null mice are embryonic-lethal by embryonic day 8.5. The mechanism of the unexpectedly early lethality involves the interaction of non-3-hydroxylated embryonic type IV collagen with the maternal platelet-specific glycoprotein VI (GPVI). This interaction results in maternal platelet aggregation, thrombosis of the maternal blood, and death of the embryo. The phenotype is completely rescued by producing double KOs of P3H2 and GPVI. Double nulls are viable and fertile. Under normal conditions, subendothelial collagens bear the GPVI-binding sites that initiate platelet aggregation upon blood exposure during injuries. In type IV collagen, these sites are normally 3-hydroxylated. Thus, prolyl 3-hydroxylation of type IV collagen has an important function preventing maternal platelet aggregation in response to the early developing embryo. A unique link between blood coagulation and the ECM is established. The newly described mechanism may elucidate some unexplained fetal losses in humans, where thrombosis is often observed at the maternal/fetal interface. Moreover, epigenetic silencing of P3H2 in breast cancers implies that the interaction between GPVI and non-3-hydroxylated type IV collagen might also play a role in the progression of malignant tumors and metastasis.

Original languageEnglish (US)
Pages (from-to)161-166
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Collagen Type IV
Hydroxylation
Collagen
Platelet Aggregation
Mothers
Glycoproteins
Thrombosis
Embryonic Structures
Maternal Death
Blood Coagulation
Post Translational Protein Processing
Basement Membrane
Epigenomics
Binding Sites
Breast Neoplasms
Neoplasm Metastasis
Phenotype
Wounds and Injuries
Neoplasms
Proteins

ASJC Scopus subject areas

  • General

Cite this

Biological role of prolyl 3-hydroxylation in type IV collagen. / Pokidysheva, Elena; Boudko, Sergei; Vranka, Janice; Zientek, Keith; Maddox, Kerry; Moser, Markus; Fässler, Reinhard; Ware, Jerry; Bächinger, Hans Peter.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 1, 2014, p. 161-166.

Research output: Contribution to journalArticle

Pokidysheva, E, Boudko, S, Vranka, J, Zientek, K, Maddox, K, Moser, M, Fässler, R, Ware, J & Bächinger, HP 2014, 'Biological role of prolyl 3-hydroxylation in type IV collagen', Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 1, pp. 161-166. https://doi.org/10.1073/pnas.1307597111
Pokidysheva, Elena ; Boudko, Sergei ; Vranka, Janice ; Zientek, Keith ; Maddox, Kerry ; Moser, Markus ; Fässler, Reinhard ; Ware, Jerry ; Bächinger, Hans Peter. / Biological role of prolyl 3-hydroxylation in type IV collagen. In: Proceedings of the National Academy of Sciences of the United States of America. 2014 ; Vol. 111, No. 1. pp. 161-166.
@article{3e9ceb614e0f4b82995d3be9436575df,
title = "Biological role of prolyl 3-hydroxylation in type IV collagen",
abstract = "Collagens constitute nearly 30{\%} of all proteins in our body. Type IV collagen is a major and crucial component of basement membranes. Collagen chains undergo several posttranslational modifications that are indispensable for proper collagen function. One of these modifications, prolyl 3-hydroxylation, is accomplished by a family of prolyl 3-hydroxylases (P3H1, P3H2, and P3H3). The present study shows that P3H2-null mice are embryonic-lethal by embryonic day 8.5. The mechanism of the unexpectedly early lethality involves the interaction of non-3-hydroxylated embryonic type IV collagen with the maternal platelet-specific glycoprotein VI (GPVI). This interaction results in maternal platelet aggregation, thrombosis of the maternal blood, and death of the embryo. The phenotype is completely rescued by producing double KOs of P3H2 and GPVI. Double nulls are viable and fertile. Under normal conditions, subendothelial collagens bear the GPVI-binding sites that initiate platelet aggregation upon blood exposure during injuries. In type IV collagen, these sites are normally 3-hydroxylated. Thus, prolyl 3-hydroxylation of type IV collagen has an important function preventing maternal platelet aggregation in response to the early developing embryo. A unique link between blood coagulation and the ECM is established. The newly described mechanism may elucidate some unexplained fetal losses in humans, where thrombosis is often observed at the maternal/fetal interface. Moreover, epigenetic silencing of P3H2 in breast cancers implies that the interaction between GPVI and non-3-hydroxylated type IV collagen might also play a role in the progression of malignant tumors and metastasis.",
author = "Elena Pokidysheva and Sergei Boudko and Janice Vranka and Keith Zientek and Kerry Maddox and Markus Moser and Reinhard F{\"a}ssler and Jerry Ware and B{\"a}chinger, {Hans Peter}",
year = "2014",
doi = "10.1073/pnas.1307597111",
language = "English (US)",
volume = "111",
pages = "161--166",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "1",

}

TY - JOUR

T1 - Biological role of prolyl 3-hydroxylation in type IV collagen

AU - Pokidysheva, Elena

AU - Boudko, Sergei

AU - Vranka, Janice

AU - Zientek, Keith

AU - Maddox, Kerry

AU - Moser, Markus

AU - Fässler, Reinhard

AU - Ware, Jerry

AU - Bächinger, Hans Peter

PY - 2014

Y1 - 2014

N2 - Collagens constitute nearly 30% of all proteins in our body. Type IV collagen is a major and crucial component of basement membranes. Collagen chains undergo several posttranslational modifications that are indispensable for proper collagen function. One of these modifications, prolyl 3-hydroxylation, is accomplished by a family of prolyl 3-hydroxylases (P3H1, P3H2, and P3H3). The present study shows that P3H2-null mice are embryonic-lethal by embryonic day 8.5. The mechanism of the unexpectedly early lethality involves the interaction of non-3-hydroxylated embryonic type IV collagen with the maternal platelet-specific glycoprotein VI (GPVI). This interaction results in maternal platelet aggregation, thrombosis of the maternal blood, and death of the embryo. The phenotype is completely rescued by producing double KOs of P3H2 and GPVI. Double nulls are viable and fertile. Under normal conditions, subendothelial collagens bear the GPVI-binding sites that initiate platelet aggregation upon blood exposure during injuries. In type IV collagen, these sites are normally 3-hydroxylated. Thus, prolyl 3-hydroxylation of type IV collagen has an important function preventing maternal platelet aggregation in response to the early developing embryo. A unique link between blood coagulation and the ECM is established. The newly described mechanism may elucidate some unexplained fetal losses in humans, where thrombosis is often observed at the maternal/fetal interface. Moreover, epigenetic silencing of P3H2 in breast cancers implies that the interaction between GPVI and non-3-hydroxylated type IV collagen might also play a role in the progression of malignant tumors and metastasis.

AB - Collagens constitute nearly 30% of all proteins in our body. Type IV collagen is a major and crucial component of basement membranes. Collagen chains undergo several posttranslational modifications that are indispensable for proper collagen function. One of these modifications, prolyl 3-hydroxylation, is accomplished by a family of prolyl 3-hydroxylases (P3H1, P3H2, and P3H3). The present study shows that P3H2-null mice are embryonic-lethal by embryonic day 8.5. The mechanism of the unexpectedly early lethality involves the interaction of non-3-hydroxylated embryonic type IV collagen with the maternal platelet-specific glycoprotein VI (GPVI). This interaction results in maternal platelet aggregation, thrombosis of the maternal blood, and death of the embryo. The phenotype is completely rescued by producing double KOs of P3H2 and GPVI. Double nulls are viable and fertile. Under normal conditions, subendothelial collagens bear the GPVI-binding sites that initiate platelet aggregation upon blood exposure during injuries. In type IV collagen, these sites are normally 3-hydroxylated. Thus, prolyl 3-hydroxylation of type IV collagen has an important function preventing maternal platelet aggregation in response to the early developing embryo. A unique link between blood coagulation and the ECM is established. The newly described mechanism may elucidate some unexplained fetal losses in humans, where thrombosis is often observed at the maternal/fetal interface. Moreover, epigenetic silencing of P3H2 in breast cancers implies that the interaction between GPVI and non-3-hydroxylated type IV collagen might also play a role in the progression of malignant tumors and metastasis.

UR - http://www.scopus.com/inward/record.url?scp=84891960136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891960136&partnerID=8YFLogxK

U2 - 10.1073/pnas.1307597111

DO - 10.1073/pnas.1307597111

M3 - Article

C2 - 24368846

AN - SCOPUS:84891960136

VL - 111

SP - 161

EP - 166

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 1

ER -